SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boston Scientific announced it received FDA 510(k) ...

Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke or ...

LONDON--(BUSINESS WIRE)--The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Okami Medical has raised $45 million to commercialize ...